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Glucocorticoids were long believed to primarily function through cytosolic glucocorticoid receptor (GR)
activation and subsequent classical genomic pathways. Recently, however, evidence has emerged that
suggests the presence of rapid non-genomic GR-dependent signaling pathways within the brain, though
their existence in spinal and peripheral nociceptive neurons remains elusive. In this paper, we aim to
systemically identify GR within the spinal cord and periphery, to verify their putative membrane location
and to characterize possible G protein coupling and pain modulating properties. Double immunoﬂuo-
rescence confocal microscopy revealed that GR predominantly localized in peripheral peptidergic and
non-peptidergic nociceptive C- and Ad-neurons and existed only marginally in myelinated mechanore-
ceptive and proprioreceptive neurons. Within the spinal cord, GR predominantly localized in incoming
presynaptic nociceptive neurons, in pre- and postsynaptic structures of the dorsal horn, as well as in
microglia. GR saturation binding revealed that these receptors are linked to the cell membrane of sensory
neurons and, upon activation, they trigger membrane targeted [35S]GTPgS binding, indicating G protein
coupling to a putative receptor. Importantly, subcutaneous dexamethasone immediately and dose-
dependently attenuated acute nociceptive behavior elicited in an animal model of formalin-induced
pain hypersensitivity compared to naive rats. Overall, this study provides ﬁrm evidence for a novel
neuronal mechanism of GR agonists that is rapid, non-genomic, dependent on membrane binding and G
protein coupling, and acutely modulates nociceptive behavior, thus unraveling a yet unconsidered
mechanism of pain relief.
© 2016 Published by Elsevier Ltd.1. Introduction
It is well established that glucocorticoid receptors (GR) func-
tion through classical genomic pathways in which the glucocor-
ticoid is bound to the receptor, this complex then acts as a nuclearsiology and Intensive Care
linikum and Campus Charite
.
ousa).transcription factor and ﬁnally regulates the transcription of
speciﬁc genes, a process that usually takes several hours (De Kloet
et al., 1998). One of the best examples of this genomic pathway is
the immunosuppressive effect of glucocorticoids, which inhibits
inﬂammatory processes and is commonly used in the treatment of
painful arthritis (Garg et al., 2014). However, apart from these
rather long-term properties, glucocorticoids are also able to elicit
very rapid effects, e.g, on ion channels within the hippocampus of
the brain (Chatterjee and Sikdar, 2014; Groeneweg et al., 2012). For
example, it has been reported that corticosterone inhibits NMDA
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campal neurons by using patch-clamp techniques (Liu et al., 2007).
Moreover, it has been shown that topical corticosteroid applica-
tion to peripheral neurons immediately blocked the transmission
of nerve impulses (Johansson et al., 1990). These actions occur
rapidly and independently of gene expression and, therefore,
support the notion that GR may also act via non-genomic path-
ways on speciﬁc membrane receptors to inﬂuence cell signaling
(Chatterjee and Sikdar, 2014; Groeneweg et al., 2012; L€osel and
Wehling, 2003).
Since the ﬁrst report on the successful treatment of sciatic
pain by the administration of hydrocortisone (Lievre et al., 1953),
glucocorticoids have been well perceived and widely used for
their pain relieving effects (Rijsdijk et al., 2014). In addition to
their systemic application, they have been successfully used both
perineurally and intrathecally in combination with local anes-
thetics, but there is a lack of knowledge concerning the true
mechanism and site of action (Knezevic et al., 2015; Albrecht
et al., 2015). Until recently, it was believed that the therapeutic
effect is mainly due to glucocorticoids' antiphlogistic mechanism
of action either on immune cells or on activated glia cells
(Albrecht et al., 2015). Therefore, previous animal studies focused
primarily on the late assessment of glucocorticoids' anti-
nociceptive effects, e.g., after several weeks, (Kingery et al., 2001;
Pinto-Ribeiro et al., 2009). However, emerging evidence suggests
that glucocorticoids may also have a direct effect on neurons
(Chatterjee and Sikdar, 2014; Groeneweg et al., 2012; Johansson
et al., 1990).
To date there has been no demonstration of membrane-bound
GR on sensory neurons being responsible for alterations in noci-
ceptive behavior through rapid, non-genomic effects. Therefore, we
have set out to identify the distinct nociceptive neurons as well as
glia cells that express GR in the periphery and spinal cord of naive
rats. Our goal is to determine the neurons' functional role under
resting conditions and situations of acute nociceptive stimulation,
to characterize GR-speciﬁc membrane binding sites, and ﬁnally to
test whether activation of these membrane located GR results in
[35S]GTPgS binding, indicating G protein coupling to a putative
membrane receptor, thus unraveling a yet unconsidered mecha-
nism of pain relief.
2. Methods
2.1. Reagents
The following drugs were used: isoﬂurane (1.0e2.5 vol%, Abbott,
Wiesbaden, Germany); GR agonist dexamethasone (Sigma-Aldrich,
St. Louis, MO, USA); dexamethasone was dissolved in a vehicle
composed of 10% ethanol and saline by volume as described pre-
viously (Coderre and Yashpal, 1994). Routes and volumes of drug
administrationwere i.t. 20 mL, i.pl. 100 mL and s.c. 100 mL. Intrathecal
injections were administered through a Hamilton syringe under
inhalation anesthesia. The drugs or its solvent were injected into
the L3eL4 intrathecal interspace (spontaneous tail movement be-
ing a positive indication for correct i.t. positioning) with a 30-gauge
needle connected to a 50 mL syringe (Shaqura et al., 2016). Intra-
plantar injections were given under inhalational anesthesia into
the subcutaneous tissue of the glabrous skin directly proximal to
the callosities of the toes. Subcutaneous injections were given un-
der the loose skin of the back between the shoulder blades. In
accordance with previous studies (Coderre and Yashpal, 1994),
separate groups of animals for each dose and injection technique
received i.pl., i.t. or s.c. administrations of different doses of dexa-
methasone (i.t. 2e20 mg, i.pl. 5e100 mg or s.c. 0.5e5 mg/kg) or
vehicle in a blinded fashion.2.2. Animals
Experiments were conducted in male Wistar rats (200e250 g)
(breeding facility, Charite-Universit€atsmedizin Berlin, Germany and
Semmelweis University Budapest) after approval by the local ani-
mal care committee and in accordance with the European Directive
introducing new animal welfare and care guidelines (2010/63/EU).
2.3. GR mRNA detection by RT-PCR
Total RNA was extracted from the kidney, spinal cord and L3-5
DRG (L3-L5 DRG pooled) of Wistar rats (n ¼ 6) using RNeasy Kit
(Qiagen, Hilden, Germany) as previously described (Mousa et al.,
2016; Shaqura et al., 2016). The following speciﬁc primers for GR
were used: Forward primer: 50-CATCTTCAGAACAGCAAAATCGA-30,
Reverse primer: 50-AGGTGCTTTGGTCT GTGGGATA-30 (Ensembl,
Accession Nr: NM_012576.2). Taqman® Real-Time PCR (Taqman®
7500, Applied Biosystems) was performed with a SYBR® Green
master mix following the manufacturer's instructions (Applied
Biosystems, Carlsbad, CA). Ampliﬁcation was carried out for 40
cycles, each consisting of 15 s at 95 C for GR and 18S of 30 s at
60 C. A temperature just below the speciﬁc melting temperature
(Tm) was employed for detection of ﬂuorescence speciﬁc products
(GR: Tm 83 C, 18S: Tm 88 C). GR mRNA was quantiﬁed using
triplicates of each sample using the delta-delta CTmethod (Shaqura
et al., 2016). The housekeeping gene 18S (Accession No. NR_046237,
Forward primer: CGGCTA CCACATCCAAGGAA Reverse Primer:
GCTGGAATTACCGCGGCT) was used as an internal reference gene.
Experiments were done in triplicate.
2.4. Western blot
Kidney, DRG (L3-L5 DRG pooled), spinal cord and sciatic nerve
from adult rats (n ¼ 4) were solubilized according to Mousa et al.
(2016) to obtain total cell protein. Western blot analyses were
performed in duplicate as previously described (Mousa et al., 2016;
Shaqura et al., 2016). After blotting the membranes were blocked in
3% BSA for 2 h and incubated with rabbit anti-GR (a gift from M.
Kawata, Kyoto Prefectural University of Medicine, Japan; 1:4000 in
3% BSA) overnight at 4 C. This antibody has been proven in
different cell lines to be highly speciﬁc following GR-transfection
and knock-down (Ito et al., 2000; Han et al., 2005). After incuba-
tion with the secondary antibody (peroxidase-conjugated goat
anti-rabbit, 1:40.000, Jackson ImmunoResearch, West Grove, PA)
for 2 h at room temperature, reactive protein bands were digitally
visualized using ECL solutions (SuperSignal West Pico, Thermo
Scientiﬁc) in ChemiDoc MP Imager.
2.5. Immunohistochemistry
After perfusion of the rats spinal cord, DRG, sciatic nerve and
subcutaneous paw tissue were removed and further processed as
described previously (Mousa et al., 2016; Shaqura et al., 2016). The
sections were then incubated over night with the following pri-
mary antibodies (see antibodies information's in Table 1): poly-
clonal rabbit antibodies against GR in combination with a
polyclonal guinea pig anti-CGRP, goat polyclonal anti-trkA, anti-
trkB, anti-trkC, anti-RET, monoclonal mouse anti-TH, anti-NF200,
anti-S100b, anti-CD11b, anti-GFAP, anti-PSD-95, anti-EAAC1, anti-
GluN1/NR1, anti-GluR1 or FITC-conjugated IB4. The GR antibody
(M. Kawata) has previously been shown in COS-1 cells with or
without GR transfection to be highly speciﬁc (Han et al., 2005).
Finally, the tissues were washed in PBS, mounted in vectashield
(Vector Laboratories) and imaged on a confocal laser scanning
microscope, LSM510 as described previously (Shaqura et al., 2016).
Table 1
Characterization of primary antibodies used.
Antigen Immunogen Manufacturer, species, type, Catalogue number Dilution
used
GR A part of the rat GR transcription modulation domain A gift fromM. Kawata (Kyoto Prefectural University of Medicine,
Japan), rabbit polyclonal, # Ito et al., 2000
1:3.000
GR A peptide mapping at the N-terminus of GR of mouseorigin (Santa Cruz Biotechnology, California) GR (M-20), rabbit
polyclonal # sc-1004, # McKlveen et al., 2013
1:200
CGRP Synthetic entire calcitonin gene-related peptide Peninsula Laboratories (CA, USA), guinea pig polyclonal, # T-
5027 # Mousa et al., 2013
1:1.000
NF200 Carboxy terminal tail segment of dephosphorylated NF200 Sigma-Aldrich (USA), mouse monoclonal #N0142/N52 # Kestell
et al., 2015
1:1.000
SV2 Synaptic vesicle glycoprotein 2A, clone SV2A Developmental Studies Hybridoma Bank, (IA, USA), mouse
monoclonal # AB-2315387 # Wahlin et al., 2010
1:1.000
S-100 (b-subunit) Bovine brain S-100b clone SH-B1 Sigma-Aldrich (USA), mouse monoclonal, #S2532 # Tanga et al.,
2006
1:1.000
TH An epitope in the midportion of the TH molecule Immunostar Inc. (WI, USA), mouse monoclonal, #22941 #
Bergl€of et al., 2007
1:2.000
trkA Extracellular domain Ala33-Pro418 of rat trkA R&D Systems (USA), goat polyclonal, # AF1056 # Matsumoto
et al., 2012
1:500
trkB Extracellular domain Cys32-Thr429 of recombinant mouse trkB R&D Systems (USA), goat polyclonal, # AF1494 # Matsumoto
et al., 2012
1:500
trkC Extracellular domain Cys32-Thr429 of recombinant mouse trkC R&D Systems (USA), goat polyclonal, # AF1404 # Matsumoto
et al., 2012
1:500
Ret Mouse myeloma cell line NS0 derived recombinant mouse Ret
Leu29Arg637
R&D Systems (USA), goat polyclonal, # AF482 # Young et al.,
2003
1:300
EAAC1 Fusion protein amino acids 115-208 (extracellular domain) of
rat EAAC1
NeuroMab (University of California, Davis/NIH), mouse
monoclonal, #73-428 #RRID: AB_2532046
1:1.000
GluN1/NR1 (NMDAR1) Fusion protein amino acids 42-361 (extracellular N-terminus) of
rat GluN1/NR1
NeuroMab (University of California, Davis/NIH), mouse
monoclonal, #75-272, #RRID:AB_11000180
1:1.000
PSD-95 Fusion protein amino acids 77-299 of human PSD-95 NeuroMab (University of California, Davis/NIH), mouse
monoclonal, #75-028, # RRID: AB_2292909
1:1.000
GFAP clone G-A-5 Sigma-Aldrich (USA), mouse monoclonal #G3893
# Liu et al., 2012
1:1.000
CD11b clone OX-42 AbD Serotec (Germany), mouse monoclonal # MCA275R #
Robinson et al., 1986
1:1.000
M. Shaqura et al. / Neuropharmacology 111 (2016) 1e13 3To demonstrate staining speciﬁcity, the following controls were
included as described in our previous studies (Mousa et al., 2016):
1) omission of either the primary antisera or the secondary
antibodies.
The method of quantiﬁcation for DRG staining has been
described previously (Mousa et al., 2016; Shaqura et al., 2016). For
counting of the total number of neurons, only those immuno-
stained neurons containing a distinct nucleus were counted using
themicroscope (40 objective). In a similar way, the number of GR/
total DRG, mineralocorticoid receptor (MR)/total DRG, GR/MR-,
CGRP/GR-, trkA/GR-, trkB/GR-, trkC/GR-, NF200/GR-, GFAP/GR- or
OX42/GR-IR neurons were counted and divided by the total num-
ber of GR-IR neurons in each DRG section and represented as per-
centages. Data show the means of 2e3 ﬁelds of n ¼ 5 rats by a
blinded observer.
2.6. Von Frey ﬁlament testing
Rats were placed in a plastic cage for half an hour to acclimate
until cage exploration and major grooming activities ceased. At the
bottom of the cage, a wire mesh allowed full access to the paws.
Mechanical hind paw withdrawal thresholds were assessed by the
application of a calibrated series of von Frey ﬁlaments of logarith-
mic incremental stiffness (Stoelting, Wood Dale, IL, USA) as
described previously (Shaqura et al., 2016). Brieﬂy, the resulting
pattern of positive and negative responses were tabulated using the
convention, X ¼ withdrawal; 0 ¼ no withdrawal, and the 50%
response threshold was interpolated using the formula: 50% g
threshold ¼ (10(xfþkd))/10,000, where xf¼ value (in log units) of the
ﬁnal von Frey ﬁlament used; k ¼ tabular value for the pattern of
positive/negative responses; and d ¼mean difference (in log units)
between stimuli. After baseline measurements, von Frey thresholdswere reevaluated at different time intervals before and 0e60 min
after i.pl. or i.t. injection of vehicle or the GR agonist dexametha-
sone. The mechanical paw withdrawal thresholds were deﬁned as
themean of 5e6 animals performed before and after i.pl. or i.t. drug
injections.
2.7. Formalin test
As an animal model of acutely evoked nociceptive behavior, the
formalin test was performed as described by Coderre and Yashpal
(1994). Brieﬂy, to habituate the animals (n ¼ 28) to the proced-
ure, rats were wrapped in cloth with only their hindlimb free for
three consecutive days prior to the experiments (“handling”). On
the day of formalin injection, the rats were similarly wrapped in
cloth and restrained by one researcher, while the other researcher
injected a 2.5% solution of formalin into the plantar surface of the
right hind paw in a volume of 50 ml/rat. Then, animals were moved
into Plexiglas observation chambers (25  25  25 cm3) placed on
glass ﬁxed over a mirror of 45 angle to allow free viewing of the
paws. Immediately after formalin injection, the number of shaking,
biting and licking behavior of the injected paw was counted. Two
observation phases, phase I (0e10 min) and phase II (11e60 min)
were chosen to assess the accumulated pain behavior. Different
doses (0.1e5.0 mg/kg body weight) of dexamethasone or vehicle
were s.c. administered 15 min prior the formalin challenge.
2.8. Radioligand binding assay
Membranes were obtained from the lumbar (L3-5) DRG, and
[3H]Corticosterone and [35S]GTPgS binding assays were performed
as described previously (Mousa et al., 2016; Shaqura et al., 2016).
Saturation binding experiments were performed using GR agonist
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lytic, Germany). 50e100 mg of membrane protein was incubated
with various concentrations of 1.25e40 nM [3H]Corticosterone and
10 mMof the unlabeled GR ligand corticosterone for 1 h at 22 C in a
total volume of 1 ml of binding buffer (50 mM TriseHCl, 5 mM
EDTA, 5 mMMgCl2, 100 mM NaCl, 0.2% bovine serum albumin). All
experiments were performed in duplicate and carried out at least
ﬁve times. Bmax and Kd values in saturation binding assays were
determined by nonlinear regression analysis of concentration-
effect curves using GraphPad Prism (GraphPad Software Inc., CA,
USA).
For [35S]GTPgS binding assay DRG membranes were incubated
in [35S]GTPgS (speciﬁc Activity 1000 Ci/mmol, Hartmann Ana-
lytic, Germany) assay buffer containing 50 mM TriseHCl, pH 7.4,
5 mM MgCl2, 0.2 mM EGTA, 100 mM NaCl, and 1 mM dithio-
threitol. Concentration-effect curves were generated by incu-
bating the appropriate concentration of membranes (30e50 mg)
and varying concentrations of dexamethasone (1012e104 M),
with 30 mM GDP and 0.05 nM [35S]GTPgS in a total volume of
800 ml. Basal values were obtained in the absence of agonist, and
nonspeciﬁc binding was measured in the presence of 10 mM
unlabeled GTPgS. The reaction mixture was incubated for 2 h at
30 C. Bound and free [35S]GTPgS were separated by vacuum
ﬁltration through GF/B ﬁlters and quantiﬁed by liquid scintilla-
tion counting. All experiments were performed in duplicate and
carried out ﬁve times.2.9. Statistical analysis
All tests were performed using Sigma Stat 2.03 software (SPSS
Inc., Germany). GR mRNA data are expressed as means ± s.e.m. Paw
withdrawal thresholds determined by von Frey ﬁlament testing as
well as nociceptive behavioral events determined by formalinFig. 1. Detection of GR mRNA and protein in rat kidney, spinal cord (SC), dorsal root gang
PCR in kidney, spinal cord, dorsal root ganglia of naive rats. A: the ampliﬁcation proﬁles of
mRNA expression relative to the expression in kidneys of naive rats (experiments were done
antibody shows GR speciﬁc protein bands from kidney, SC, DRG and SN of naive rats with
noﬂuorescence of GR (red ﬂuorescence) with MR (green ﬂuorescence) (Bar ¼ 40 mm). C and
number of DRG neurons per visual ﬁeld being 58.9 ± 7.5% and 35.6 ± 5.6%, respectively (dat
more GR-IR than MR-IR neurons and 31.3 ± 5.9% of total DRG neurons showed colocalizatio
ﬁgure legend, the reader is referred to the web version of this article.)testing were expressed as means ± s.e.m and statistically analyzed
by repeated measurement ANOVA and one-way ANOVA plus post-
hoc Dunnett's test, respectively. For all statistical tests, signiﬁcance
was assumed at P < 0.05.
3. Results
3.1. GR speciﬁc mRNA and protein identiﬁcation in DRG and spinal
cord
GR mRNA transcripts were detected in kidney, spinal cord and
DRG tissue of naive rats using quantitative Taqman® RT-PCR. PCR
products showed primer speciﬁc hybridization curves and charac-
teristic crossing points for GR mRNA in rat spinal cord and DRG
similar to rat kidney (Fig. 1A). Translation of this mRNA into GR
protein was revealed by our Western blot analysis of respective
tissue extracts showing GR-immunoreactive bands at the expected
molecular weight of 87 kDa (Fig. 1B), consistent with previous GR
protein demonstration at a similar molecular weight in rat brain
neurons (Han et al., 2005).
3.2. GR localization proﬁle of distinct DRG neurons
Identiﬁcation of DRG neuron subtypes that reveal GR immu-
noreactivity in naive rats by use of several neuron speciﬁc
markers such as CGRP, trkA (peptidergic nociceptive C-type
neurons), IB4 and/or RET (non-peptidergic nociceptive neurons),
NF-200 (neuroﬁlament 200 as marker for myelinated A-type
neurons in DRG), trkB (Ad-type neurons) and trkC (Ab-type
neurons) (Le Pichon and Chesler, 2014) demonstrated that GR-IR
neurons co-localized predominantly with non-peptidergic IB4-
(54.2 ± 3.9%) and RET-IR neurons (47.1 ± 7.1%) and to a lesser
degree with peptidergic CGRP-IR neurons (36.8 ± 12.7%) (Fig. 2).lia (DRG) and sciatic nerve (SN). Quantiﬁcation of GR mRNA using Taqman® Real-Time
the 18S- and GR-speciﬁc cDNA of naive rats and the column graph representing % GR
in triplicate from n ¼ 6 rats). B: Western blot analysis with a rabbit polyclonal anti-GR
an expected molecular weight of 87 kDa. C-E: Confocal microscopy of double immu-
D show the number (means ± SD) of GR-IR and MR-IR neurons in relation to the total
a show means ± SD of 2e3 ﬁelds of n ¼ 5 rats). Also, note that DRG contained 1.7-fold
n of GR and MR (E). Bar ¼ 40 mm. (For interpretation of the references to colour in this
M. Shaqura et al. / Neuropharmacology 111 (2016) 1e13 570% of GR-IR neurons did not show colocalization with NF200
(Fig. 2) indicating that they are unmyelinated. We conﬁrmed the
colocalization of GR with CGRP using another GR polyclonal
antibody (M-20, Santa Cruz) (Supplemental Fig. 1). Similar to the
extent of GR colocalization with CGRP- and NF200, GR colocalized
with trkA (33.6 ± 7.0%) and trkB (26.3 ± 3.9%) (Fig. 3). There was
only little colocalization between GR and trkC (12.6 ± 4.1%)
(Fig. 3). Moreover, the number of GR-IR and MR-IR DRG neurons
in relation to the total number of DRG neurons per visual ﬁeld
were 58.9 ± 7.5% and 35.6 ± 5.6%, respectively (Fig. 1C, D), indi-
cating that DRG contained 1.7-fold more GR-IR than MR-IR neu-
rons. Approximately 31.3 ± 5.9% of total DRG neurons showed a
colocalization of GR with MR (Fig. 1E). GR were not identiﬁed in
satellite cells of DRG. These ﬁndings indicate that e in addition toFig. 2. Confocal microscopy of double immunoﬂuorescence of GR (red ﬂuorescence) wi
coexistence of GR (red) with IB4, RET, CGRP, or NF200 (green) with some cells showing IB4
number of DRG neurons coexpressing GR with IB4 (54.2 ± 3.9%), RET (47.1 ± 7.1%), CGRP (36
Bar ¼ 40 mm. (For interpretation of the references to colour in this ﬁgure legend, the readeGR expressing peptidergic CGRP-/trkA-IR sensory neurons e they
are localized to a major part in nociceptive non-peptidergic IB4-
and RET-IR DRG neurons (Honda et al., 1999), however, much less
in mechanoreceptive and proprioceptive neurons (Le Pichon and
Chesler, 2014).
3.3. GR localization proﬁle of nociceptive neurons in sciatic nerve
and skin
In sections of the sciatic nerve and longitudinal sections of skin
nerves GR-immunoreactive nerve ﬁbres colocalized with CGRP
almost to the same extent as was shown for DRG sections (Fig. 4A).
Consistently, the majority of nerve ﬁbres of the sciatic nerve and
skin showed immunoreactivity for CGRP or GR alone. GR-IR nerveth IB4, RET, CGRP, or NF200 (green ﬂuorescence) in DRG of naive rats. AeD images:
, RET, CGRP, or NF200 staining alone. AeD columns: Quantitative analysis shows the
.8 ± 12.7%) or NF200 (29.5 ± 3.9%). Data show means ± SD of 2e3 ﬁelds of n ¼ 5 rats.
r is referred to the web version of this article.)
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epidermal layer, where they usually extended into the epidermis
(Fig. 4B). Most notably, GR-immunoreactivity strongly colocalized
with S100-IR Schwann cells in both sciatic nerve and skin (Fig. 4C,
D). In the skin GR-IR cells were also identiﬁed as keratinocytes
within the basal layer of the epidermis (Fig. 4D) as well as TH-ir
nerve ﬁbres in the immediate vicinity of arterial vessels (data not
shown).
3.4. GR expression proﬁle of nociceptive neurons and glia in the
spinal cord
In the spinal cord, GR colocalized to some degree (approxi-
mately 30%) with the neuropeptide CGRP in presynaptic nocicep-
tive nerve terminals incoming fromDRG to Rexed laminae I and II of
the dorsal horn (Fig. 5A), whereas the majority of spinal CGRP
staining did not colocalize with GR. In addition, GR-IR nerve ﬁbres
colocalized with non-peptidergic RET-IR neurons from the pe-
riphery in lamina I and II of the dorsal horn (see Jongen et al., 2007),
however, there was no overlap with NF200 (Fig. 5B).
Next, we examined the co-localization of GR with several
neuronal markers for synaptic proteins: glutamate receptor sub-
type N-methyl-D-aspartate (NMDA) (GluN1/NR1) and Glutamate
receptor 1 (GluR1), glutamate transporters EAAC-1 (excitatory
amino acid carrier). Interestingly, a large number of cell proﬁles
expressing GR also expressed GluN1/NR1, GluR1 and EAAC-1
within the superﬁcial laminae of the spinal dorsal horn (Figs. 5
and 6). Consistently, GR immunorectivity co-localized with post-
synaptic density protein 95 (PSD-95) in the dorsal horn of the
spinal cord indicating a close cellular association between GR and
GluN1/NR1 and GluR1 on postsynaptic neurons (Fig. 6). InFig. 3. Confocal microscopy of GR (red ﬂuorescence) and trkA, trkB or trkC (green ﬂuores
DRG neurons coexpressing GR with trkA (33.6 ± 7.0%) is much higher than those coexpressin
rats). Bar ¼ 40 mm. (For interpretation of the references to colour in this ﬁgure legend, theaddition, GR colocalized with the microglia marker OX-42 but
only scarcely with the astrocyte marker GFAP in lamina I and II of
the grey matter as well as within the white matter of the spinal
cord (Fig. 7).
3.5. GR impact on nociception in naive rats and in rats with acute
nociceptive stimulation
Toassess the functional relevanceofGRonnociceptiveneurons,we
evaluated possible alterations in mechanical withdrawal thresholds
during von Frey ﬁlament testing following the i.pl. and i.th. adminis-
tration of increasing doses of the GR agonist dexamethasone in naive
rats. The results showed that over a large dose range of dexametha-
sone therewasnosigniﬁcant change inmechanical thresholdsofnaive
rats (Fig. 8A, B). However, when we tested s.c. dexamethasone
administration in a rat model of acute nociceptive stimulation by i.pl.
injection of formalin we observed a dose-dependent inhibition of
characteristic pain behavior such as shaking, biting and licking
particularly in the secondphase (11e60min), butnot in theﬁrstphase
(0e10 min) of the formalin test (P < 0.05; Fig. 8C).
3.6. GR speciﬁc binding sites and [35S]GTPgS coupling in
membranes of rat DRG neurons
In membrane fractions of DRG extracts of naive rats, increasing
concentrations of [3H]corticosterone in the presence of 10 mM unla-
beled corticosterone led to the identiﬁcation of GR speciﬁc binding
sites with a saturation curve that showed a Bmax value of
112 ± 18.5 fmol/mg protein and a Kd value of 16.9 ± 6.1 nM (Fig. 8D).
More interestingly, increasing concentrations of the GR agonist
dexamethasone resulted in saturated [35S]GTPgS couplingmost likelycence) double immunoﬂuorescence in DRG of naive rats. Note that the population of
g trkB (26.3 ± 3.9%) or trkC (12.6 ± 4.1%). Data show means ± SD of 2e3 ﬁelds of n ¼ 5
reader is referred to the web version of this article.)
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(P < 0.05; one-way ANOVA and Dunnett's test) (Fig. 8E).
4. Discussion
This study provides ﬁrst evidence for acute pain inhibition by
the GR-selective agonist dexamethasone through rapid non-
genomic effects. These effects are most likely mediated by aFig. 4. Confocal microscopy of double immunoﬂuorescence of GR (red ﬂuorescence) wit
colocalization of GR immunoreactive nerve ﬁbres (red) with the neuropeptide CGRP (green)
epidermal layer of the skin which usually extend into the epidermis (B); C-D: colocalization o
nerve ﬁbres of subcutaneous tissue (C) and branching nerve terminals into the sub-epiderm
basal layer of the epidermis (D). Representative sections of n ¼ 5 rats. Bar ¼ 20 mm. (For inte
web version of this article.)putative, membrane-bound G protein-coupled receptor on pe-
ripheral nociceptive neurons. Herewe show that GR predominantly
localize on peripheral nociceptive C- and Ad-neurons and only
scarcely on populations of myelinated mechanoreceptive and pro-
prioreceptive neurons. In the spinal cord, GR exist in presynaptic
nociceptive nerve terminals incoming fromDRG to Rexed Laminae I
and II, as well as postsynaptic structures within the superﬁcial
dorsal horn. In contrast to a lack of MR localization in glia cellsh CGRP or S100 (green ﬂuorescence) in sciatic nerve and subcutaneous tissue. AeB:
in nerve ﬁbres of the sciatic nerve (A) and in branching nerve terminals within the sub-
f GR immunoreactivity (red) with the Schwann cell marker S100 (green) accompanying
al layer of the skin (D); note that the magniﬁed insert shows GR-IR keratinocytes in the
rpretation of the references to colour in this ﬁgure legend, the reader is referred to the
M. Shaqura et al. / Neuropharmacology 111 (2016) 1e138(Shaqura et al., 2016), GR are prominent in Schwann cells of pe-
ripheral nerves and in spinal microglia but only rarely present in
astrocytes. Importantly, i.pl. or i.t. application of dexamethasone
does not alter mechanical sensitivity in naive animals, but its s.c.
application immediately inhibits acute nociceptive behavior eli-
cited in an animal model of formalin-induced pain hypersensitivity.
Consistently, the activation of GR speciﬁc membrane binding sitesFig. 5. Confocal microscopy of double immunoﬂuorescence of GR (red ﬂuorescence) with
A, B: show that GR colocalized to some degree with CGRP or RET in presynaptic nocicept
whereas the majority of spinal CGRP or RET immunoreactivity did not colocalize with GR. C
GR also expressed EAAC-1 within the superﬁcial laminae of the spinal dorsal horn. Represen
references to colour in this ﬁgure legend, the reader is referred to the web version of thisin peripheral sensory neurons leads to saturated [35S]GTPgS
coupling.4.1. GR localization proﬁle in sensory DRG neurons and periphery
Using RT-PCR we were able to isolate GR speciﬁc transcripts
from rat spinal cord and DRG similar to control tissue such asCGRP, RET, NF200 or EAA (green ﬂuorescence) in the dorsal horn of the spinal cord.
ive nerve terminals incoming from DRG to Rexed laminae I and II of the dorsal horn,
: There was almost no overlap with NF200. D: shows that some cell proﬁles expressing
tative sections of n ¼ 5 rats. AeC Bar ¼ 20 mm, D Bar ¼ 40 mm. (For interpretation of the
article.)
M. Shaqura et al. / Neuropharmacology 111 (2016) 1e13 9kidney tissue. These ﬁndings are consistent with former in situ
hybridization studies demonstrating GR-hybridization products in
the brain and spinal cord (Marlier et al., 1995; Aronsson et al., 1988)
and GR mRNA in the spinal cord (Patacchioli et al., 1998; Marlier
et al., 1996). To prove that GR transcripts were indeed translated
into receptor proteins, we performed Western Blot analysis that
showed a single GR speciﬁc protein band at the expectedmolecular
weight in kidney, spinal cord and DRG neurons, consistent with GRFig. 6. Confocal microscopy of double immunoﬂuorescence of GR (red ﬂuorescence) with
Transverse sections of the spinal cord showing the majority of cell proﬁles coexpress GR (re
horn. D: longitudinal sections of the spinal cord showing colocalization of GR- (red) with PSD
Bar ¼ 20 mm. (For interpretation of the references to colour in this ﬁgure legend, the readeprotein demonstration at a similar molecular weight in rat brain
neurons (Han et al., 2005).
Previous immunohistochemical studies stated that GR coexist
with the neuropeptides substance P and CGRP in a speciﬁc sub-
population of DRG neurons (DeLeon et al., 1994). Extending these
earlier ﬁndings, we demonstrate now that GR do not only colocalize
with peptidergic CGRP-IR nociceptive neurons but more so with
non-peptidergic IB4-IR/RET-IR DRG neurons. The former have beenNMDR, GluR or PSD (green ﬂuorescence) in the dorsal horn of the spinal cord. AeC:
d) with NMDR, GluR or PSD (green) within the superﬁcial laminae of the spinal dorsal
- (green) immunoreactivity. Representative sections of n ¼ 5 rats. A, B Bar ¼ 40 mm, C, D
r is referred to the web version of this article.)
M. Shaqura et al. / Neuropharmacology 111 (2016) 1e1310suggested to address rather the sensory discriminative component
of pain, whereas the latter focuses on the affective emotional
component of the pain experience (Braz et al., 2005). Therefore, GR
distribution in DRG neurons is quite distinct from MR-IR sensory
neurons in the way that MR colocalize to a much higher degree
(approximately 75%) with CGRP (Shaqura et al., 2016). In the pre-
sent study, 34% of GR-IR DRG neurons show trkA immunoreactivity
to a similar degree as their CGRP expression, deﬁning them as
nociceptive C-ﬁbres (Matsumoto et al., 2012). On the other hand,
much less GR-IR neurons seem to colocalize with trkB as well as
trkC, thus suggesting that only few GR-IR neurons function as
cutaneous Ad nociceptors or Ab mechanoreceptors (Matsumoto
et al., 2012). This is consistent with the notion that the majority
of GR-IR nociceptive neurons (~70%) prove to be unmyelinated
neurons.
In addition to sensory neurons, we identiﬁed GR in numerous
S100-IR Schwann cells that accompanied peripheral nerves in the
skin in contrast to MR, which showed no colocalization with
Schwann or glia cells (Shaqura et al., 2016). Earlier reports have
suggested a functional role of GR in glucocorticoid-induced
Schwann cell proliferation (Neuberger et al., 1994), myelination
(Morisaki et al., 2010), regeneration (Morisaki et al., 2010) and gene
expression (Girard et al., 2010). In the skin, we also identiﬁed GR-IR
cells in keratinocytes within the basal layer of the epidermis,Fig. 7. Confocal microscopy of double immunoﬂuorescence of GR (red ﬂuorescence) w
spinal cord. A: scarce colocalization of GR-immunoreactivity (red) with the astrocyte ma
immunoreactivity (red) with the microglia marker OX-42 (green) in the dorsal grey a
Bar ¼ 20 mm, C Bar ¼ 40 mm. (For interpretation of the references to colour in this ﬁgure lconsistent with the long history of glucocorticoids as therapeutic
agents for numerous skin diseases (Stojadinovic et al., 2007). Taken
together, our ﬁndings indicate that GR are predominantly
expressed in nociceptive peptidergic and nonpeptidergic nocicep-
tive C- and Ad-neurons, yet much less in mechanoreceptive and
proprioceptive neurons (Matsumoto et al., 2012). This implies the
receptors' crucial role in modulating various aspects of nociception.
4.2. GR expression proﬁle of nociceptive neurons and glia of the
spinal cord
At the spinal level, double ﬂuorescence confocal microscopy
predominantly colocalized GR with incoming peptidergic CGRP-IR
and non-peptidergic RET-IR nerve ﬁbres in Rexed Lamina I and II
of the dorsal horn. Earlier studies reported GR localization espe-
cially in substance P- and CGRP-IR DRG neurons (DeLeon et al.,
1994). Further supportive evidence, showed that corticosterone
deprivation by adrenalectomy alters the content of both neuro-
peptides in primary afferent neurons (Smith et al., 1991). However,
GR colocalization with non-peptidergic RET-IR neurons was still
unknown.
In contrast to a former study that reported an overlap between
GR and EAAC1 expression in the spinal cord (Wang et al., 2006), our
results show that EAAC1 immunoreactivity in GR-expressing spinalith GFAP or OX-42 (green ﬂuorescence) in the dorsal grey and white matter of the
rker GFAP (green) throughout the dorsal horn; B, C: abundant colocalization of GR-
nd white matter of the spinal cord. Representative sections of n ¼ 5 rats. A, B
egend, the reader is referred to the web version of this article.)
Fig. 8. Role of GR in pain behavior, membrane binding and [35S]GTPgS coupling. AeC: von Frey ﬁlament or formalin testing of mechanical sensitivity following the local
i.pl., i.t. or s.c. application of dexamethasone. A, B: show that there was no signiﬁcant change in mechanical thresholds of naive rats (n ¼ 5e6) in response to i.pl. (A) or i.t. (B)
injection of increasing doses of the GR agonist dexamethasone (P > 0.05, repeated measurement ANOVA). C: shows that s.c. dexamethasone signiﬁcantly and dose dependently
reduced formalin-induced pain behavior (shaking, biting and licking responses) in the second phase (11e60 min) but not in the ﬁrst phase (0e10 min) of the formalin test (P < 0.05,
ANOVA and Dunnett's test, n ¼ 7). D, E) Saturation binding analysis of GR speciﬁc binding sites (D) and [35S]GTPgS coupling (E) to cell membranes of DRG neurons. (D) In naive rats
(n ¼ 5), increasing concentrations of [3H]Corticosterone in the presence of 10 mM unlabeled speciﬁc GR agonist corticosterone led to a speciﬁc saturation curve with a Bmax value of
112 ± 18.5 fmol/mg protein and a Kd value of 16.9 ± 6.1 nM (E) shows that increasing concentrations of the GR agonist dexamethasone resulted in saturated [35S]GTPgS-coupling
most likely due to GR-induced G protein coupling (EC50 ¼ 0.46 ± 0.03 mM). Data represent experiments from 5 rats in duplicate and are expressed as means ± SEM.
M. Shaqura et al. / Neuropharmacology 111 (2016) 1e13 11neurons within the dorsal horn of the spinal cord is scarce in naive
rats. In addition, we were able to demonstrate that GR colocalize to
a great extent with pre- and postsynaptic NMDA receptors, GluR1,
and PSD, consistent with the known modulatory role of glucocor-
ticoids in synaptic processes such as neurotransmission, biogenic
amine content, lipid metabolism, and speciﬁc enzyme activity (De
Nicola et al., 1998). In addition to spinal neurons, GR are also
expressed in OX-42-IR microglial cells both in the grey and white
matter of the spinal cord, though much less in GFAP-IR astrocytes.
Evidence for the presence of GR in primary cultures of spinal glia
cells has been demonstrated in earlier studies (Chantong et al.,
2012; Sierra et al., 2008), and immunohistochemical evidence has
previously only been shown in various brain areas, such as the
hippocampus (Cintra et al., 1994).4.3. Functional role of GR in nociception
In oder to examine the functional role of these spinal and pe-
ripheral GR, we applied increasing doses of the GR-selective agonist
dexamethasone into the hindpaw or intrathecal space of naive rats
and tested possible alterations in mechanical sensitivity with von
Frey ﬁlaments. The doses were chosen based on previous publica-
tions that showed signiﬁcant effects on nociceptive behavior in
different animal models of pain (Min et al., 2014; Zhang et al., 2014;
Gu et al., 2011). However, in naive rats we did not ﬁnd any signif-
icant change in mechanical thresholds following either i.pl. or i.th.
administration of dexamethasone. This contrasts with the i.pl. and
i.t. application of MR agonists which resulted in acute mechanical
sensitization (Shaqura et al., 2016) yet is in line with previous
in vivo evidence that dexamethasone applied to silent nociceptive
neurons does not modulate A- or C-ﬁber conduction (Johansson
et al., 1990; Devor et al., 1985). On the other hand, dexametha-
sone substantially reduced the incidence of spontaneous ectopic
discharge generated in experimental nerve end neuromas (Devoret al., 1985) or inhibited the transmission of electrical impulses in
C-, but not Ab-nerve ﬁbres (Johansson et al., 1990). We therefore
tested the modulatory effects of the GR-selective agonist dexa-
methasone in an animal model of acute nociceptive stimulation
such as the formalin test. Indeed, s.c. injection of dexamethasone
resulted in the dose-dependent inhibition of formalin-evoked
nociceptive behavior corroborating previous ﬁndings of anti-
nociceptive effects following the spinal application of dexametha-
sone (Min et al., 2014; Coderre and Yashpal, 1994). Since the
inhibition of nociceptive behavior occurred within 15e20 min and
persisted for approximately 60 min after dexamethasone applica-
tion, this questions the traditionally held presumption that the
inhibition occurs through genomic mechanisms. Instead, recent
evidence shows that neuronal GR agonists may also elicit their ef-
fects through non-genomic ways (Chatterjee and Sikdar, 2014;
Groeneweg et al., 2012). These non-genomic pathways can be eli-
cited either by directly interfering with intracellular signaling
pathways or by interfering with membrane-bound structures such
as ion channels and/or G-protein coupled receptors (Chatterjee and
Sikdar, 2014; Groeneweg et al., 2012).4.4. Membrane localization and G protein coupling of sensory
neuron GR
Thus, we further corroborated the evidence for a putative non-
genomic pathway by demonstrating GR binding sites in mem-
brane fractions of DRG neurons of naive rats similar to its previous
demonstration in the brain (Orchinik et al., 1992). Our immuno-
ﬂuorescence confocal microscopy consistently showed that GR
immunoreactivity was not identiﬁable in the nuclear but rather in
the cytosol/plasma membrane compartment of DRG neurons in
naive rats. The presence of GR has also been shown in synaptosome
extracts of the brain (Komatsuzaki et al., 2005; Wang and Wang,
2009) and, as enriched densities, at neuronal plasma membranes
M. Shaqura et al. / Neuropharmacology 111 (2016) 1e1312using electron microscopy (Johnson et al., 2005; Prager et al., 2010).
In addition to GRmembrane binding, we observed for the ﬁrst time
that increasing concentrations of the GR agonist dexamethasone
resulted in saturated [35S]GTPgS coupling, most likely due to a
putative G protein coupled receptor. This coupling has been pre-
viously postulated for neurons in the brain as there is accumulating
evidence for the formation of a ternary complex of steroid, receptor
and guanine nucleotide-binding protein (Orchinik et al., 1992) and
for inhibitors of G proteins that abolish many glucocorticoid effects
(Groeneweg et al., 2012). In addition, dexamethasone has been
shown to activate postsynaptic, membrane-associated receptors
and G protein signaling. This elicits a rapid suppression of excit-
atory postsynaptic inputs or a rapid nitric oxide-dependent in-
crease in inhibitory postsynaptic inputs (Naher et al., 2015). Taken
together, these ﬁndings strongly suggest a potential rapid, non-
genomic mechanism for GR mediated pain control most likely
occurring through the involvement of a G protein coupled receptor.
5. Conclusions
Taken together, this study provides ﬁrm evidence for the
expression of GR being predominantly in nociceptive (unmyelin-
ated C-ﬁbres and Adﬁbres) but much less in mechanoreceptive
and proprioceptive neurons (myelinated large diameter Ab-ﬁbres)
of DRG and the periphery of naive rats. In addition, GR co-localize
with incoming presynaptic nociceptive nerve terminals, gluta-
matergic pre- and postsynaptic structures, however much less with
microglia and astrocytes within the dorsal horn of spinal cord. The
results furnish functional evidence for a novel neuronal mechanism
of GR agonists in nociceptive neurons that has been previously
explored in other neuronal networks. This mechanism in nocicep-
tive neurons is rapid, non-genomic, dependent on membrane
binding and G protein coupling, and acutely modulates nociceptive
behavior, thus unraveling a yet unconsidered mechanism of pain
relief.
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